Skip to content
★ Sign in to follow
K(

Kontour (Xi'an) Medical Technology Co., Ltd. Stock: price and insider trades · China

康拓医疗

CN·Mcap CN¥2.3BHealth Care

Kontour (Xi'an) Medical Technology Co., Ltd.: what insiders have been doing

Kontour (Xi'an) Medical Technology Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Over the twelve months to 4 November 2026, 2 filings were filed, from 2 insiders.

All open-market trades in the period are sales: 2 sales worth €2.9M, by 2 insiders, with no purchase on record. Biggest ticket of the year: €1.7M, sold by 朱海龙 and made public on 23 April 2026.

Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

With 2 filings in twelve months, the company is in line with the median of 2 filings across the 517 companies we follow on the same exchange. Looking back to 2022, when coverage begins, insiders filed no purchases and 9 sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
9
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€6M
9 ops. · all time

Who traded when

BuySale
朱海龙4 sales
吴栋1 sale
胡立功1 sale
赵若愚1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 6,847 of 26,914 companies
64.0
score / 100
Value
47
Quality
81
FCF yld2.9%
Earn yld4.3%
EV/EBITDA17.8x
ROE12%
Gross mgn79%
Net mgn28%
Debt/EBITDA0.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥28.00
Analyst consensus
·
Income statement
RevenueCN¥351.1M
Gross profitCN¥276.3M79% margin
EBITDACN¥133.4M38% margin
Net incomeCN¥98.7M24.2% margin
Valuation
PER (trailing)26.9x
P/Book3.1x
Beta-0.04
Balance sheet & cash
Market capCN¥2.3B
Total debtCN¥87.7M
Free Cash FlowCN¥66.7M
Debt / Equity13%
Profitability & ownership
ROE11.7%
ROA7.3%
% insiders63.4%
% institutions4.7%
Last declaration on 23 April 2026
Declarations9 total
  • ▼
    董事Executives
    14M CNY23SSE
    300,000 shares40.8% of flowA股XSHGSSE:273000000492959260
  • ▼
    董事Executives
    9M CNY27SSE
    200,000 shares100.0% of flowA股XSHGSSE:273000000492959230
  • ▼
    董事Executives
    1M CNY27SSE
    37,636 shares100.0% of flowA股XSHGSSE:173000008920685820
  • ▼
    董事Executives
    3M CNY8SSE
    100,000 shares8.2% of flowA股XSHGSSE:173000008891591420
  • ▼
    董事Executives
    3M CNY20SSE
    100,000 shares8.6% of flowA股XSHGSSE:173000008661322370
  • ▼
    董事Executives
    3M CNY20SSE
    100,000 shares8.8% of flowA股XSHGSSE:173000008657689150
  • ▼
    董事Executives
    4M CNY27SSE
    150,000 shares100.0% of flowA股XSHGSSE:173000008657689180
  • ▼
    董事,高级管理人员Executives
    6M CNY9SSE
    200,000 shares18.6% of flowA股XSHGSSE:173000006818992030
  • ▼
    董事,高级管理人员Executives
    4M CNY8SSE
    93,000 shares14.9% of flowA股XSHGSSE:173000005599082980

9 of 9 declarations

About Kontour (Xi'an) Medical Technology Co., Ltd.

康拓医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations